Abstract
Parkinson’s disease (PD) is a progressive movement disorder characterized by neuroinflammation and dopaminergic neurodegeneration in the brain. 1-methyl-4-phenylpyridinium (MPP+), a metabolite of the parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces the release of inflammatory mediators from glial cells and neurons. Glia maturation factor (GMF), a brain proinflammatory protein, MPP+ , and mast cell-derived inflammatory mediators induce neurodegeneration which eventually leads to PD. However, the precise mechanisms underlying interaction between glial cells, neurons and mast cells in PD still remain elusive. In the present study, mouse bone marrow-derived mast cells (BMMCs) and mouse fetal brain-derived mixed glia/neurons, astrocytes and neurons were incubated with MPP+, GMF and mast cell-derived inflammatory mediators mouse mast cell protease-6 (MMCP-6), MMCP-7 or tryptase/brain-specific serine protease-4 (tryptase/BSSP-4). Inflammatory mediators released from these cells in the culture medium were quantitated by enzyme-linked immunosorbent assay. Neurodegeneration was quantified by measuring total neurite outgrowth following microtubule-associated protein-2 immunocytochemistry. MPP+-induced significant neurodegeneration with reduced total neurite outgrowth. MPP+induced the release of tryptase/BSSP-4 from the mouse mast cells, and tryptase/BSSP-4 induced chemokine (C-C motif) ligand 2 (CCL2) release from astrocytes and glia/neurons. Overall our results suggest that MPP+, GMF, MMCP-6 or MMCP-7 stimulate glia/neurons, astrocytes or neurons to release CCL2 and matrix metalloproteinase-3. Additionally, CD40L expression is increased in BMMCs after incubation with MPP+ in a co-culture system consisting of BMMCs and glia/neurons. We propose that mast cell interaction with glial cells and neurons during neuroinflammation can be explored as a new therapeutic target for PD.
Similar content being viewed by others
References
Bennett JL, Blanchet MR, Zhao L, Zbytnuik L, Antignano F, Gold M, Kubes P, McNagny KM (2009) Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis. J Immunol 182:5507–5514
Brahmachari S, Jana A, Pahan K (2009) Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 183:5917–5927
Caughey GH (2007) Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev 217:141–154
Chikahisa S, Kodama T, Soya A, Sagawa Y, Ishimaru Y, Sei H, Nishino S (2013) Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states. PLoS One 8:e78434
Cottrell GS, Amadesi S, Schmidlin F, Bunnett N (2003) Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 31:1191–1197
Cui Y, Dahlin JS, Feinstein R, Bankova LG, Xing W, Shin K, Gurish MF, Hallgren J (2014) Mouse mast cell protease-6 and MHC are involved in the development of experimental asthma. J Immunol 193:4783–4789
Dong H, Zhang X, Wang Y, Zhou X, Qian Y, Zhang S (2016) Suppression of brain mast cells degranulation inhibits microglial activation and central nervous system inflammation. Mol Neurobiol 54:997–1007
Frieri M, Kumar K, Boutin A (2015) Role of mast cells in trauma and neuroinflammation in allergy immunology. Ann Allergy Asthma Immunol 115:172–177
Grimmig B, Morganti J, Nash K, Bickford PC (2016) Immunomodulators as therapeutic agents in mitigating the progression of Parkinson's disease. Brain Sci 6. https://doi.org/10.3390/brainsci6040041
Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382–397
Jin Y, Silverman AJ, Vannucci SJ (2009) Mast cells are early responders after hypoxia-ischemia in immature rat brain. Stroke 40:3107–3112
Johnson JL, Jackson CL, Angelini GD, George SJ (1998) Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 18:1707–1715
Kalesnikoff J, Galli SJ (2008) New developments in mast cell biology. Nat Immunol 9:1215–1223
Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE (2013) Alpha-Synuclein oligomers and clinical implications for Parkinson disease. Ann Neurol 73:155–169
Kaplan R, Zaheer A, Jaye M, Lim R (1991) Molecular cloning and expression of biologically active human glia maturation factor-beta. J Neurochem 57:483–490
Kempuraj D, Khan MM, Thangavel R, Xiong Z, Yang E, Zaheer A (2013) Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J NeuroImmune Pharmacol 8:643–650
Kempuraj D, Thangavel R, Yang E, Pattani S, Zaheer S, Santillan DA, Santillan MK, Zaheer A (2015) Dopaminergic toxin 1-Methyl-4-Phenylpyridinium, proteins alpha-Synuclein and glia maturation factor activate mast cells and release inflammatory mediators. PLoS One 10:e0135776
Kempuraj D, Thangavel R, Fattal R, Pattani S, Yang E, Zaheer S, Santillan DA, Santillan MK, Zaheer A (2016) Mast cells release chemokine CCL2 in response to Parkinsonian toxin 1-Methyl-4-phenyl-Pyridinium (MPP(+)). Neurochem Res 41:1042–1049
Khan MM, Kempuraj D, Zaheer S, Zaheer A (2014) Glia maturation factor deficiency suppresses 1-Methyl-4-Phenylpyridinium-induced oxidative stress in astrocytes. J Mol Neurosci 53:590–599
Khan MM, Zaheer S, Thangavel R, Patel M, Kempuraj D, Zaheer A (2015) Absence of glia maturation factor protects dopaminergic neurons and improves motor behavior in mouse model of parkinsonism. Neurochem Res 53:590–599
Kim DY, Jeoung D, Ro JY (2010) Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J Immunol 185:273–283
Kim DY, Hong GU, Ro JY (2011) Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation 8:25
Lee EJ, Woo MS, Moon PG, Baek MC, Choi IY, Kim WK, Junn E, Kim HS (2010a) Alpha-synuclein activates microglia by inducing the expressions of matrix metalloproteinases and the subsequent activation of protease-activated receptor-1. J Immunol 185:615–623
Lee HJ, Kim C, Lee SJ (2010b) Alpha-synuclein stimulation of astrocytes: potential role for neuroinflammation and neuroprotection. Oxidative Med Cell Longev 3:283–287
Lee EJ, Ko HM, Jeong YH, Park EM, Kim HS (2015) Beta-Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia. J Neuroinflammation 12:133
Li Z, Zheng Z, Ruan J, Li Z, Tzeng CM (2016) Chronic inflammation links cancer and Parkinson's disease. Front Aging Neurosci 8:126
Lim R, Zaheer A (1991) Structure and function of glia maturation factor beta. Adv Exp Med Biol 296:161–164
Lim R, Miller JF, Zaheer A (1989) Purification and characterization of glia maturation factor beta: a growth regulator for neurons and glia. Proc Natl Acad Sci U S A 86:3901–3905
Lim R, Liu YX, Zaheer A (1990) Cell-surface expression of glia maturation factor beta in astrocytes. FASEB J 4:3360–3363
Lim R, Zaheer A, Khosravi H, Freeman JH Jr, Halverson HE, Wemmie JA, Yang B (2004) Impaired motor performance and learning in glia maturation factor-knockout mice. Brain Res 1024:225–232
Liu X, Wang J, Zhang H, Zhan M, Chen H, Fang Z, Xu C, Chen H, He S (2016) Induction of mast cell accumulation by Tryptase via a protease activated Receptor-2 and ICAM-1 dependent mechanism. Mediat Inflamm 2016:6431574
Madrigal JL, Caso JR (2014) The chemokine (C-C motif) ligand 2 in neuroinflammation and neurodegeneration. Adv Exp Med Biol 824:209–219
Marx CE, Jarskog LF, Lauder JM, Lieberman JA, Gilmore JH (2001) Cytokine effects on cortical neuron MAP-2 immunoreactivity: implications for schizophrenia. Biol Psychiatry 50:743–749
McKittrick CM, Lawrence CE, Carswell HV (2015) Mast cells promote blood brain barrier breakdown and neutrophil infiltration in a mouse model of focal cerebral ischemia. J Cereb Blood Flow Metab 35:638–647
Mekori YA, Metcalfe DD (2000) Mast cells in innate immunity. Immunol Rev 173:131–140
Nelissen S, Lemmens E, Geurts N, Kramer P, Maurer M, Hendriks J, Hendrix S (2013) The role of mast cells in neuroinflammation. Acta Neuropathol 125:637–650
Ni WW, Cao MD, Huang W, Meng L, Wei JF (2017) Tryptase inhibitors: a patent review. Expert Opin Ther Pat 27:919–928
Ould-yahoui A, Tremblay E, Sbai O, Ferhat L, Bernard A, Charrat E, Gueye Y, Lim NH, Brew K, Risso JJ, Dive V, Khrestchatisky M, Rivera S (2009) A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. PLoS One 4:e8289
Perez-Martinez L, Jaworski DM (2005) Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal. J Neurosci 25:4917–4929
Phani S, Loike JD, Przedborski S (2012) Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat Disord 18(Suppl 1):S207–S209
Rempe RG, Hartz AM, Bauer B (2016) Matrix metalloproteinases in the brain and blood-brain barrier: versatile breakers and makers. J Cereb Blood Flow Metab 36:1481–1507
Ronnberg E, Calounova G, Pejler G (2012) Mast cells express tyrosine hydroxylase and store dopamine in a serglycin-dependent manner. Biol Chem 393:107–112
Rosenberg GA (2009) Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 8:205–216
Rothmeier AS, Ruf W (2012) Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol 34:133–149
Saito T, Bunnett NW (2005) Protease-activated receptors: regulation of neuronal function. NeuroMolecular Med 7:79–99
Sayed BA, Walker ME, Brown MA (2011) Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis. J Immunol 186:3294–3298
Secor VH, Secor WE, Gutekunst CA, Brown MA (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191:813–822
Seeldrayers PA, Levin LA, Johnson D (1992) Astrocytes support mast cell viability in vitro. J Neuroimmunol 36:239–243
Shaik-Dasthagirisaheb YB, Conti P (2016) The role of mast cells in Alzheimer's disease. Adv Clin Exp Med 25:781–787
Silverman AJ, Sutherland AK, Wilhelm M, Silver R (2000) Mast cells migrate from blood to brain. J Neurosci 20:401–408
Sismanopoulos N, Delivanis DA, Alysandratos KD, Angelidou A, Therianou A, Kalogeromitros D, Theoharides TC (2012) Mast cells in allergic and inflammatory diseases. Curr Pharm Des 18:2261–2277
Skaper SD, Facci L (2012) Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide. Philos Trans R Soc Lond Ser B Biol Sci 367:3312–3325
Skaper SD, Giusti P, Facci L (2012) Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 26:3103–3117
Skaper SD, Facci L, Giusti P (2013a) Mast cells, glia and neuroinflammation: partners in crime? Immunology 141:314–327
Skaper SD, Facci L, Giusti P (2013b) Glia and mast cells as targets for Palmitoylethanolamide, an anti-inflammatory and Neuroprotective lipid mediator. Mol Neurobiol 48:340–352
Skaper SD, Facci L, Giusti P (2014) Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol Disord Drug Targets 13:1654–1666
Tagen M, Elorza A, Kempuraj D, Boucher W, Kepley CL, Shirihai OS, Theoharides TC (2009) Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. J Immunol 183:6313–6319
Tanzola MB, Robbie-Ryan M, Gutekunst CA, Brown MA (2003) Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol 171:4385–4391
Tetlow LC, Woolley DE (1995) Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 54:896–903
Thangavel R, Stolmeier D, Yang X, Anantharam P, Zaheer A (2012) Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease. Neuropathol Appl Neurobiol 38:572–581
Thangavel R, Kempuraj D, Stolmeier D, Anantharam P, Khan M, Zaheer A (2013) Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain. Neurochem Res 38:1777–1784
Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochim Biophys Acta 1822:21–33
Tore F, Tuncel N (2009) Mast cells: target and source of neuropeptides. Curr Pharm Des 15:3433–3445
Walker ME, Hatfield JK, Brown MA (2012) New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action? Biochim Biophys Acta 1822:57–65
Wang BR, Zaheer A, Lim R (1992) Polyclonal antibody localizes glia maturation factor beta-like immunoreactivity in neurons and glia. Brain Res 591:1–7
Woo MS, Park JS, Choi IY, Kim WK, Kim HS (2008) Inhibition of MMP-3 or −9 suppresses lipopolysaccharide-induced expression of proinflammatory cytokines and iNOS in microglia. J Neurochem 106:770–780
Zaheer A, Fink BD, Lim R (1993) Expression of glia maturation factor beta mRNA and protein in rat organs and cells. J Neurochem 60:914–920
Zaheer A, Yorek MA, Lim R (2001) Effects of glia maturation factor overexpression in primary astrocytes on MAP kinase activation, transcription factor activation, and neurotrophin secretion. Neurochem Res 26:1293–1299
Zaheer A, Mathur SN, Lim R (2002) Overexpression of glia maturation factor in astrocytes leads to immune activation of microglia through secretion of granulocyte-macrophage-colony stimulating factor. Biochem Biophys Res Commun 294:238–244
Zaheer A, Zaheer S, Sahu SK, Knight S, Khosravi H, Mathur SN, Lim R (2007) A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. J Neurochem 101:364–376
Zaheer A, Knight S, Zaheer A, Ahrens M, Sahu SK, Yang B (2008a) Glia maturation factor overexpression in neuroblastoma cells activates glycogen synthase kinase-3beta and caspase-3. Brain Res 1190:206–214
Zaheer A, Zaheer S, Thangavel R, Wu Y, Sahu SK, Yang B (2008b) Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage. Brain Res 1208:192–203
Zaheer S, Wu Y, Sahu SK, Zaheer A (2011a) Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody. Brain Res 1373:230–239
Zaheer S, Thangavel R, Sahu SK, Zaheer A (2011b) Augmented expression of glia maturation factor in Alzheimer's disease. Neuroscience 194:227–233
Zhang S, Zeng X, Yang H, Hu G, He S (2012) Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell Physiol Biochem 29:931–940
Zhang X, Wang Y, Dong H, Xu Y, Zhang S (2016) Induction of microglial activation by mediators released from mast cells. Cell Physiol Biochem 38:1520–1531
Acknowledgements
The Flow cytometry data presented herein were obtained at the Flow Cytometry Facility, which is a Carver College of Medicine/Holden Comprehensive Cancer Center core research facility at the University of Iowa, Iowa City, IA. The Facility is funded through user fees and the generous financial support of the Carver College of Medicine, Holden Comprehensive Cancer Center, and Iowa City Veteran’s Administration Medical Center. We thank Mr. Justin Fishbaugh, Technical Director, Flow Cytometry Facility for his help in Flow Cytometry data acquisition and analysis in this study.
Funding
This work was supported by Veteran Affairs Merit Award I01BX002477 and National Institutes of Health Grants AG048205 & NS073670 to AZ.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The Committee on the Ethics of Animal Experiments of the University of Iowa (Iowa City, IA) and the University of Missouri (Columbia, MO) approved the protocol.
Conflict of Interest
Authors declare that they have no competing interests.
Rights and permissions
About this article
Cite this article
Kempuraj, D., Selvakumar, G.P., Zaheer, S. et al. Cross-Talk between Glia, Neurons and Mast Cells in Neuroinflammation Associated with Parkinson’s Disease. J Neuroimmune Pharmacol 13, 100–112 (2018). https://doi.org/10.1007/s11481-017-9766-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-017-9766-1